Trials / Unknown
UnknownNCT01206946
Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants
Effect of Antenatal Steroids for Women at Risk of Late Preterm Delivery on Neonatal Respiratory Morbidity
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 700 (estimated)
- Sponsor
- American University of Beirut Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years – 49 Years
- Healthy volunteers
- Not accepted
Summary
The hypothesis of the study is that administration of antenatal steroid to women at high risk of preterm birth after 34 weeks of gestation would reduce the risk of respiratory complications, specifically Respiratory Distress Syndrome (RDS) or Transient Tachypnea of the Newborn (TTN) in late preterm babies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Betamethasone | A single course of betamethasone (two doses of 12 mg/dose given at 24 hourly intervals) |
| OTHER | Normal Saline | Two doses of 2ml of normal saline given at 24 hourly intervals |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2010-09-22
- Last updated
- 2011-06-23
Locations
5 sites across 1 country: Lebanon
Source: ClinicalTrials.gov record NCT01206946. Inclusion in this directory is not an endorsement.